CD28 and neoplasm: Also, a similar CD44low CD62L+ arrest was observed in CD8+ T cells activated with anti-CD3/CD28 and co-cultured with tumor-MDSC or bone marrow-derived MDSC (BM-MDSC) (Figure 1B), confirming the inhibitory effect of MDSC on TEFF differentiation.